Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

CytoTherapeutics sells Encapsulated Cell Technology to Neurotech

Jan. 4, 2000

No Comments

Medarex and IDM establish broad collaborative agreement

Jan. 3, 2000

No Comments

AxyS Advanced Technologies and Cephalon to collaborate in combinatorial chemistry

Dec. 30, 1999

No Comments

Abgenix cleared to become sole owner of XenoMouse technology

Dec. 28, 1999

No Comments

Bayer allies with MorphoSys to accelerate drug discovery

Dec. 28, 1999

No Comments

Transkaryotic Therapies achieves milestone in Aventis collaboration

Dec. 23, 1999

No Comments

Cambridge NeuroScience issued two patents, three patent allowances

Dec. 23, 1999

No Comments

Aurora Biosciences announces two ion channel technology agreements

Dec. 23, 1999

No Comments

Two new patents issued to Helix for drug delivery technology

Dec. 22, 1999

No Comments

Immune Response acquires T-cell receptor technology from Connetics and Xoma

Dec. 16, 1999

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Drug design, drug delivery and technologies, BioWorld Science
RSS

CytoTherapeutics sells Encapsulated Cell Technology to Neurotech

Medarex and IDM establish broad collaborative agreement

AxyS Advanced Technologies and Cephalon to collaborate in combinatorial chemistry

Abgenix cleared to become sole owner of XenoMouse technology

Bayer allies with MorphoSys to accelerate drug discovery

Transkaryotic Therapies achieves milestone in Aventis collaboration

Cambridge NeuroScience issued two patents, three patent allowances

Aurora Biosciences announces two ion channel technology agreements

Two new patents issued to Helix for drug delivery technology

Immune Response acquires T-cell receptor technology from Connetics and Xoma

Today's news in brief

Today's news in brief

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

Proteomics study explores how protein changes influence disease

Abbvie and Simcere enter a $1B T-cell engager deal

Drug design, drug delivery and technologies, BioWorld Science RSS

Drug design, drug delivery and technologies, BioWorld Science
RSS